Pharma-Bio Serv, Inc. (PBSV) › Operating Cash FlowPharma-Bio Serv, Inc. (PBSV) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: $466.3K2011: $2.14M2012: $2.46M2013: $5.63M2014: $3.33M2015: $372.6K2016: $709.7K2017: -$922.7K2018: $3.72M2019: -$2.21M2020: $1.51M2021: $804.8K2022: $592.5K2023: $1.89M2024: -$566.7K2025: -$214.9K-$214.9K2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$214.9K+62.1%2024-$566.7K-130.0%2023$1.89M+219.2%2022$592.5K-26.4%2021$804.8K-46.9%2020$1.51M+168.6%2019-$2.21M-159.4%2018$3.72M+503.0%2017-$922.7K-230.0%2016$709.7K+90.5%2015$372.6K-88.8%2014$3.33M-40.8%2013$5.63M+128.8%2012$2.46M+14.9%2011$2.14M+358.9%2010$466.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share